KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Other Accumulated Expenses (2018 - 2025)

Historic Other Accumulated Expenses for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to $1.7 million.

  • ClearPoint Neuro's Other Accumulated Expenses rose 4863.95% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 4863.95%. This contributed to the annual value of $1.4 million for FY2024, which is 3770.18% up from last year.
  • Latest data reveals that ClearPoint Neuro reported Other Accumulated Expenses of $1.7 million as of Q3 2025, which was up 4863.95% from $1.2 million recorded in Q2 2025.
  • ClearPoint Neuro's Other Accumulated Expenses' 5-year high stood at $2.1 million during Q4 2022, with a 5-year trough of $473000.0 in Q1 2021.
  • For the 5-year period, ClearPoint Neuro's Other Accumulated Expenses averaged around $1.2 million, with its median value being $1.2 million (2024).
  • Per our database at Business Quant, ClearPoint Neuro's Other Accumulated Expenses skyrocketed by 28454.38% in 2022 and then tumbled by 4900.73% in 2023.
  • ClearPoint Neuro's Other Accumulated Expenses (Quarter) stood at $537000.0 in 2021, then skyrocketed by 284.54% to $2.1 million in 2022, then plummeted by 49.01% to $1.1 million in 2023, then skyrocketed by 37.7% to $1.4 million in 2024, then increased by 20.55% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $1.2 million for Q2 2025, and $1.5 million during Q1 2025.